Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Cochran

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|October 1, 2021
Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before SeroconversionOliver F Wirz, Katharina Röltgen, Bryan A Stevens, et al.
Nature Methods|July 15, 2020
Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animalsYichi Su, Joel R Walker, Yunhee Park, et al.
Cytokine|January 25, 2020
Multi-phase catheter-injectable hydrogel enables dual-stage protein-engineered cytokine release to mitigate adverse left ventricular remodeling following myocardial infarction in a small animal model and a large animal modelAmanda N Steele, Michael J Paulsen, Hanjay Wang, et al.
Cell Reports|June 28, 2025
VISTA immune checkpoint blunts radiotherapy-induced antitumor immune responseDhanya K Nambiar, Sainiteesh Maddineni, Jimpi Langthasa, et al.
Nature Medicine|November 8, 2016
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responsesKelly D Moynihan, Cary F Opel, Gregory L Szeto, et al.
Cell|April 28, 2022
Enhanced safety and efficacy of protease-regulated CAR-T cell receptorsLouai Labanieh, Robbie G Majzner, Dorota Klysz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
Antibodies specifically targeting a locally misfolded region of tumor associated EGFRThomas P J Garrett, Antony W Burgess, Hui K Gan, et al.
Nature Communications|May 19, 2022
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitroLeiping Zeng, Yanxia Liu, Xammy Huu Nguyenla, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild IllnessKatharina Röltgen, Oliver F Wirz, Bryan A Stevens, et al.
Science Immunology|December 8, 2020
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcomeKatharina Röltgen, Abigail E Powell, Oliver F Wirz, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|October 1, 2021
Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before SeroconversionOliver F Wirz, Katharina Röltgen, Bryan A Stevens, et al.
Nature Methods|July 15, 2020
Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animalsYichi Su, Joel R Walker, Yunhee Park, et al.
Cytokine|January 25, 2020
Multi-phase catheter-injectable hydrogel enables dual-stage protein-engineered cytokine release to mitigate adverse left ventricular remodeling following myocardial infarction in a small animal model and a large animal modelAmanda N Steele, Michael J Paulsen, Hanjay Wang, et al.
Cell Reports|June 28, 2025
VISTA immune checkpoint blunts radiotherapy-induced antitumor immune responseDhanya K Nambiar, Sainiteesh Maddineni, Jimpi Langthasa, et al.
Nature Medicine|November 8, 2016
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responsesKelly D Moynihan, Cary F Opel, Gregory L Szeto, et al.
Cell|April 28, 2022
Enhanced safety and efficacy of protease-regulated CAR-T cell receptorsLouai Labanieh, Robbie G Majzner, Dorota Klysz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
Antibodies specifically targeting a locally misfolded region of tumor associated EGFRThomas P J Garrett, Antony W Burgess, Hui K Gan, et al.
Nature Communications|May 19, 2022
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitroLeiping Zeng, Yanxia Liu, Xammy Huu Nguyenla, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild IllnessKatharina Röltgen, Oliver F Wirz, Bryan A Stevens, et al.
Science Immunology|December 8, 2020
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcomeKatharina Röltgen, Abigail E Powell, Oliver F Wirz, et al.
Pageof 11